uric acid has been researched along with Experimental Mammary Neoplasms in 5 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Celecoxib was administered i." | 5.31 | Chronotherapy and chronotoxicity of the cyclooxygenase-2 inhibitor, celecoxib, in athymic mice bearing human breast cancer xenografts. ( Blumenthal, RD; Burton, J; Flefleh, C; Goldenberg, DM; Lew, W; Waskewich, C, 2001) |
| "Celecoxib was administered i." | 1.31 | Chronotherapy and chronotoxicity of the cyclooxygenase-2 inhibitor, celecoxib, in athymic mice bearing human breast cancer xenografts. ( Blumenthal, RD; Burton, J; Flefleh, C; Goldenberg, DM; Lew, W; Waskewich, C, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jhuo, CF | 1 |
| Hsu, YY | 1 |
| Chen, WY | 1 |
| Tzen, JTC | 1 |
| Kuhn, S | 1 |
| Hyde, EJ | 1 |
| Yang, J | 1 |
| Rich, FJ | 1 |
| Harper, JL | 1 |
| Kirman, JR | 1 |
| Ronchese, F | 1 |
| Orvoine, RH | 1 |
| Letellier, G | 1 |
| Lapointe, Y | 1 |
| Vaage, J | 1 |
| Anderson, B | 1 |
| Chu, A | 1 |
| Blumenthal, RD | 1 |
| Waskewich, C | 1 |
| Goldenberg, DM | 1 |
| Lew, W | 1 |
| Flefleh, C | 1 |
| Burton, J | 1 |
5 other studies available for uric acid and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Attenuation of Tumor Development in Mammary Carcinoma Rats by Theacrine, an Antagonist of Adenosine 2A Receptor.
Topics: Adenosine A2 Receptor Antagonists; Animals; Female; Humans; Mammary Neoplasms, Experimental; MCF-7 C | 2021 |
Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Topics: Adaptive Immunity; Adjuvants, Immunologic; Animals; Biological Therapy; Carcinoma; CD8-Positive T-Ly | 2013 |
Systemic tolerance of osmotically induced oncolysis in rats.
Topics: Animals; Aspartate Aminotransferases; Body Weight; Diuresis; Drinking; Eating; Female; Fructose; Glu | 1983 |
Excretion of carcinoma products in irradiated C3H/He mice.
Topics: Animals; Ascites; Creatinine; Dose-Response Relationship, Radiation; Female; Kidney; Male; Mammary N | 1981 |
Chronotherapy and chronotoxicity of the cyclooxygenase-2 inhibitor, celecoxib, in athymic mice bearing human breast cancer xenografts.
Topics: Animals; Antineoplastic Agents; Aspartate Aminotransferases; Bilirubin; Blood Urea Nitrogen; Blottin | 2001 |